Mosaic trisomy 21 at amniocentesis associated with a favorable fetal outcome and perinatal progressive decrease of the trisomy 21 cell line. 2023

Chih-Ping Chen, and Shin-Wen Chen, and Liang-Kai Wang, and Schu-Rern Chern, and Peih-Shan Wu, and Fang-Tzu Wu, and Yen-Ting Pan, and Chen-Chi Lee, and Li-Feng Chen, and Chen-Wen Pan, and Yun-Yi Chen, and Wayseen Wang
Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, Taiwan; Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan; School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan; Institute of Clinical and Community Health Nursing, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Obstetrics and Gynecology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Medical Laboratory Science and Biotechnology, College of Medical and Health Science, Asia University, Taichung, Taiwan. Electronic address: cpc_mmh@yahoo.com.

OBJECTIVE We present mosaic trisomy 21 at amniocentesis associated with a favorable fetal outcome and perinatal progressive decrease of the trisomy 21 cell line. METHODS A 33-year-old woman underwent elective amniocentesis at 17 weeks of gestation because of anxiety, and the karyotype of cultured amniocytes was 47,XX,+21[4]/46,XX[13]. In 17 colonies of cultured amniocytes, four colonies had 47,XX,+21, while the other 13 colonies had 46,XX. Simultaneous array comparative genomic hybridization (aCGH) analysis on uncultured amniocytes revealed the result of arr (21) × 3 [0.32] consistent with 32% mosaicism for trisomy 21. Repeat amniocentesis performed at 25 weeks of gestation revealed 47,XX,+21[4]/46,XX[24] with four colonies of 47,XX,+21 and 24 colonies of 46, XX on cultured amniocytes, and arr 21q11.2q22.3 × 2.25 by aCGH, 19.2% mosaicism for trisomy 21 (20/104 cells) by interphase fluorescence in situ hybridization (FISH), and no uniparental disomy (UPD) 21 by quantitative fluorescence polymerase chain reaction (QF-PCR) on uncultured amniocytes. The parental karyotypes were normal, and prenatal ultrasound was unremarkable. A phenotypically normal 2815-g female baby was delivered at 38 weeks of gestation. Cytogenetic analysis on the cord blood, umbilical cord and placenta revealed the karyotype of 47,XX,+21[10]/46,XX[30]. 47,XX,+21[5]/46,XX[35] and 47,XX,+21[38]/46,XX[2], respectively. QF-PCR analysis on the DNA extracted from parental bloods, uncultured amniocytes, cord blood, umbilical cord and placenta confirmed a paternal origin of trisomy 21. When follow-up at age two months, the neonate was phenotypically normal, the peripheral blood had a karyotype of 47,XX,+21[6]/46,XX[34], and no trisomy 21 signals by interphase FISH was found on 100 buccal mucosal cells. When follow-up at age 13 months, the neonate was phenotypically normal, and the peripheral blood had a karyotype of 47,XX,+21[3]/46,XX[37]. CONCLUSIONS Mosaic trisomy 21 at amniocentesis can be a transient and benign condition, and the abnormal trisomy 21 cell line may decrease and disappear after birth.

UI MeSH Term Description Entries
D009030 Mosaicism The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from a single ZYGOTE, as opposed to CHIMERISM in which the different cell populations are derived from more than one zygote.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000649 Amniocentesis Percutaneous transabdominal puncture of the uterus during pregnancy to obtain amniotic fluid. It is commonly used for fetal karyotype determination in order to diagnose abnormal fetal conditions. Amniocenteses
D017404 In Situ Hybridization, Fluorescence A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei. FISH Technique,Fluorescent in Situ Hybridization,Hybridization in Situ, Fluorescence,FISH Technic,Hybridization in Situ, Fluorescent,In Situ Hybridization, Fluorescent,FISH Technics,FISH Techniques,Technic, FISH,Technics, FISH,Technique, FISH,Techniques, FISH
D055028 Comparative Genomic Hybridization A method for comparing two sets of chromosomal DNA by analyzing differences in the copy number and location of specific sequences. It is used to look for large sequence changes such as deletions, duplications, amplifications, or translocations. Array Comparative Genomic Hybridization,Array-Based Comparative Genomic Hybridization,Comparative Genome Hybridization,Array Based Comparative Genomic Hybridization,Comparative Genome Hybridizations,Comparative Genomic Hybridizations,Genome Hybridization, Comparative,Genome Hybridizations, Comparative,Genomic Hybridization, Comparative,Genomic Hybridizations, Comparative,Hybridization, Comparative Genome,Hybridization, Comparative Genomic,Hybridizations, Comparative Genome,Hybridizations, Comparative Genomic

Related Publications

Chih-Ping Chen, and Shin-Wen Chen, and Liang-Kai Wang, and Schu-Rern Chern, and Peih-Shan Wu, and Fang-Tzu Wu, and Yen-Ting Pan, and Chen-Chi Lee, and Li-Feng Chen, and Chen-Wen Pan, and Yun-Yi Chen, and Wayseen Wang
October 2009, Prenatal diagnosis,
Chih-Ping Chen, and Shin-Wen Chen, and Liang-Kai Wang, and Schu-Rern Chern, and Peih-Shan Wu, and Fang-Tzu Wu, and Yen-Ting Pan, and Chen-Chi Lee, and Li-Feng Chen, and Chen-Wen Pan, and Yun-Yi Chen, and Wayseen Wang
June 1992, Prenatal diagnosis,
Chih-Ping Chen, and Shin-Wen Chen, and Liang-Kai Wang, and Schu-Rern Chern, and Peih-Shan Wu, and Fang-Tzu Wu, and Yen-Ting Pan, and Chen-Chi Lee, and Li-Feng Chen, and Chen-Wen Pan, and Yun-Yi Chen, and Wayseen Wang
July 2022, Taiwanese journal of obstetrics & gynecology,
Chih-Ping Chen, and Shin-Wen Chen, and Liang-Kai Wang, and Schu-Rern Chern, and Peih-Shan Wu, and Fang-Tzu Wu, and Yen-Ting Pan, and Chen-Chi Lee, and Li-Feng Chen, and Chen-Wen Pan, and Yun-Yi Chen, and Wayseen Wang
January 1993, Genetic epidemiology,
Chih-Ping Chen, and Shin-Wen Chen, and Liang-Kai Wang, and Schu-Rern Chern, and Peih-Shan Wu, and Fang-Tzu Wu, and Yen-Ting Pan, and Chen-Chi Lee, and Li-Feng Chen, and Chen-Wen Pan, and Yun-Yi Chen, and Wayseen Wang
March 2020, Taiwanese journal of obstetrics & gynecology,
Chih-Ping Chen, and Shin-Wen Chen, and Liang-Kai Wang, and Schu-Rern Chern, and Peih-Shan Wu, and Fang-Tzu Wu, and Yen-Ting Pan, and Chen-Chi Lee, and Li-Feng Chen, and Chen-Wen Pan, and Yun-Yi Chen, and Wayseen Wang
April 2022, Fetal and pediatric pathology,
Chih-Ping Chen, and Shin-Wen Chen, and Liang-Kai Wang, and Schu-Rern Chern, and Peih-Shan Wu, and Fang-Tzu Wu, and Yen-Ting Pan, and Chen-Chi Lee, and Li-Feng Chen, and Chen-Wen Pan, and Yun-Yi Chen, and Wayseen Wang
March 2021, Taiwanese journal of obstetrics & gynecology,
Chih-Ping Chen, and Shin-Wen Chen, and Liang-Kai Wang, and Schu-Rern Chern, and Peih-Shan Wu, and Fang-Tzu Wu, and Yen-Ting Pan, and Chen-Chi Lee, and Li-Feng Chen, and Chen-Wen Pan, and Yun-Yi Chen, and Wayseen Wang
February 1987, Alcoholism, clinical and experimental research,
Chih-Ping Chen, and Shin-Wen Chen, and Liang-Kai Wang, and Schu-Rern Chern, and Peih-Shan Wu, and Fang-Tzu Wu, and Yen-Ting Pan, and Chen-Chi Lee, and Li-Feng Chen, and Chen-Wen Pan, and Yun-Yi Chen, and Wayseen Wang
June 1997, Clinical genetics,
Chih-Ping Chen, and Shin-Wen Chen, and Liang-Kai Wang, and Schu-Rern Chern, and Peih-Shan Wu, and Fang-Tzu Wu, and Yen-Ting Pan, and Chen-Chi Lee, and Li-Feng Chen, and Chen-Wen Pan, and Yun-Yi Chen, and Wayseen Wang
May 2009, Journal of perinatology : official journal of the California Perinatal Association,
Copied contents to your clipboard!